Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INSPIRE: Raltegravir in Relapsing Remitting Multiple Sclerosis
NCT01767701Phase 2Completed
- Sponsor
- Queen Mary University of London
- Start
- Apr 2013
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of raltegravir in multiple sclerosis (MS), sponsored by Queen Mary University of London. Started Apr 2013; status: completed.
02
Drugs
raltegravir
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT01767701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01767701.